Literature DB >> 33477366

Immunogenicity of Viral Vaccines in the Italian Military.

Claudia Ferlito1, Roberto Biselli2, Vincenzo Visco1, Maria Sofia Cattaruzza3, Maria Rosaria Capobianchi4, Concetta Castilletti4, Daniele Lapa4, Loredana Nicoletti5, Antonella Marchi5, Fabio Magurano5, Anna Rita Ciccaglione5, Paola Chionne5, Elisabetta Madonna5, Isabella Donatelli5, Laura Calzoletti5, Concetta Fabiani5, Michela Ileen Biondo1, Raffaela Teloni5, Sabrina Mariotti5, Gerardo Salerno1, Andrea Picchianti-Diamanti1, Simonetta Salemi1, Sara Caporuscio1, Alberto Autore6, Patrizia Lulli1, Francesco Borelli7, Marco Lastilla8, Roberto Nisini5, Raffaele D'Amelio1.   

Abstract

Military personnel of all armed forces receive multiple vaccinations and have been doing so since long ago, but relatively few studies have investigated the possible negative or positive interference of simultaneous vaccinations. As a contribution to fill this gap, we analyzed the response to the live trivalent measles/mumps/rubella (MMR), the inactivated hepatitis A virus (HAV), the inactivated trivalent polio, and the trivalent subunits influenza vaccines in two cohorts of Italian military personnel. The first cohort was represented by 108 students from military schools and the second by 72 soldiers engaged in a nine-month mission abroad. MMR and HAV vaccines had never been administered before, whereas inactivated polio was administered to adults primed at infancy with a live trivalent oral polio vaccine. Accordingly, nearly all subjects had baseline antibodies to polio types 1 and 3, but unexpectedly, anti-measles/-mumps/-rubella antibodies were present in 82%, 82%, and 73.5% of subjects, respectively (43% for all of the antigens). Finally, anti-HAV antibodies were detectable in 14% and anti-influenza (H1/H3/B) in 18% of the study population. At mine months post-vaccination, 92% of subjects had protective antibody levels for all MMR antigens, 96% for HAV, 69% for the three influenza antigens, and 100% for polio types 1 and 3. An inverse relationship between baseline and post-vaccination antibody levels was noticed with all the vaccines. An excellent vaccine immunogenicity, a calculated long antibody persistence, and apparent lack of vaccine interference were observed.

Entities:  

Keywords:  HAV; adults; influenza; measles; military; mumps; polio; rubella; vaccines; varicella

Year:  2021        PMID: 33477366      PMCID: PMC7829820          DOI: 10.3390/biomedicines9010087

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  62 in total

1.  Measles-mumps-rubella vaccine in the Italian armed forces.

Authors:  R D'Amelio; R Biselli; G Fascia; S Natalicchio
Journal:  JAMA       Date:  2000-10-25       Impact factor: 56.272

2.  Epidemiology of measles, mumps and rubella in Italy.

Authors:  G Gabutti; M C Rota; S Salmaso; B M Bruzzone; A Bella; P Crovari
Journal:  Epidemiol Infect       Date:  2002-12       Impact factor: 2.451

Review 3.  Vaccines: correlates of vaccine-induced immunity.

Authors:  Stanley A Plotkin
Journal:  Clin Infect Dis       Date:  2008-08-01       Impact factor: 9.079

4.  Future combined vaccines.

Authors:  P Bégué; E Grimprel
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

5.  Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.

Authors:  S Frey; R Dagan; Y Ashur; X Q Chen; J Ibarra; H Kollaritsch; M H Mazur; G A Poland; K Reisinger; E Walter; P Van Damme; J H Braconier; I Uhnoo; M Wahl; M M Blatter; D Clements; D Greenberg; R M Jacobson; S R Norrby; M Rowe; D Shouval; S S Simmons; J van Hattum; S Wennerholm; J O Gress
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

6.  Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection.

Authors:  Suzanne E Ohmit; Joshua G Petrie; Rachel T Cross; Emileigh Johnson; Arnold S Monto
Journal:  J Infect Dis       Date:  2011-10-12       Impact factor: 5.226

7.  Anti-polysaccharide and anti-diphtheria protective antibodies after 13-valent pneumococcal conjugate vaccination in rheumatoid arthritis patients under immunosuppressive therapy.

Authors:  Sara Caporuscio; Roberto Ieraci; Guido Valesini; Raffaela Teloni; Sabrina Mariotti; Francesca Romana Spinelli; Claudia Ferlito; Simonetta Salemi; Andrea Picchianti Diamanti; Giorgia Meneguzzi; Milica Markovic; Mayla Sgrulletti; Christina von Hunolstein; Luisa Ralli; Antonietta Pinto; Gerardo Salerno; Marco Canzoni; Maria Laura Sorgi; Bruno Laganà; Roberta Di Rosa; Roberto Nisini; Raffaele D'Amelio
Journal:  Clin Immunol       Date:  2018-07-21       Impact factor: 3.969

8.  Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity.

Authors:  S Salemi; A Picchianti-Diamanti; V Germano; I Donatelli; A Di Martino; M Facchini; R Nisini; R Biselli; C Ferlito; E Podestà; A Cappella; F Milanetti; F Rossi; R Amodeo; F Tabacco; R Di Rosa; B Laganà; R D Amelio
Journal:  Clin Immunol       Date:  2009-10-21       Impact factor: 3.969

Review 9.  Hepatitis A booster vaccination: is there a need?

Authors:  P Van Damme; J Banatvala; O Fay; S Iwarson; B McMahon; K Van Herck; D Shouval; P Bonanni; B Connor; G Cooksley; G Leroux-Roels; F Von Sonnenburg
Journal:  Lancet       Date:  2003-09-27       Impact factor: 79.321

10.  The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.

Authors:  Pierre Van Damme; Ilse De Coster; Ananda S Bandyopadhyay; Hilde Revets; Kanchanamala Withanage; Philippe De Smedt; Leen Suykens; M Steven Oberste; William C Weldon; Sue Ann Costa-Clemens; Ralf Clemens; John Modlin; Amy J Weiner; Andrew J Macadam; Raul Andino; Olen M Kew; Jennifer L Konopka-Anstadt; Cara C Burns; John Konz; Rahnuma Wahid; Christopher Gast
Journal:  Lancet       Date:  2019-06-04       Impact factor: 79.321

View more
  2 in total

Review 1.  A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Authors:  Roberto Biselli; Roberto Nisini; Florigio Lista; Alberto Autore; Marco Lastilla; Giuseppe De Lorenzo; Mario Stefano Peragallo; Tommaso Stroffolini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2022-08-22

2.  Safety of Multiple Vaccinations and Durability of Vaccine-Induced Antibodies in an Italian Military Cohort 5 Years after Immunization.

Authors:  Claudia Ferlito; Vincenzo Visco; Roberto Biselli; Maria Sofia Cattaruzza; Giulia Carreras; Gerardo Salerno; Florigio Lista; Maria Rosaria Capobianchi; Concetta Castilletti; Daniele Lapa; Guido Antonelli; Massimo Gentile; Maurizio Sorice; Gloria Riitano; Giuseppe Lucania; Valeria Riccieri; Fabrizio Mainiero; Antonio Angeloni; Marco Lucarelli; Giampiero Ferraguti; Alberto Autore; Marco Lastilla; Simonetta Salemi; Michela Ileen Biondo; Andrea Picchianti-Diamanti; Sara Caporuscio; Raffaela Teloni; Sabrina Mariotti; Roberto Nisini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2021-12-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.